COc1cc(-c2nc3n(n2)C(c2ccc(F)cc2)C(C(N)=O)=C(C)N3)cc(OC)c1OC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?